ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Oppilan Pharma Ltd · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
colitis, ulcerative, s1p; sphingosine 1 phosphate receptor;, ventyx; oppilan;, moderate or severe ulcerative colitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 908571
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.